Search Results - "Chirch, Lisa M"

Evaluation of Provider Screening Practices for Fracture Risk Assessment among Patients with HIV Disease by Mirza, Faryal, Zawadzka, Sabina, Abbate, Anne, Thompson, Michael, Wakefield, Dorothy, Chirch, Lisa M.

“…People living with HIV are known to have greater risk of low bone mineral density than HIV-negative peers. The reasons for this disparity are multifactorial…”
Get full text

Pulmonary artery intravascular abscess: A rare complication of incomplete infective endocarditis treatment in the setting of injection drug use by Gupta, Simran, Banach, David B., Chirch, Lisa M.

“…Infective endocarditis (IE) is a serious complication of injection drug use. Right-sided IE encompasses 5–10% of all IE cases, with the majority involving the…”
Get full text

Nontuberculous mycobacterial infections: a potential complication of cosmetic procedures by Hypolite, Tiara, Grant-Kels, Jane M., Chirch, Lisa M.

“…Interest in surgical and non-surgical cosmetic procedures has increased significantly over the last few decades. Billions of dollars are spent on these…”
Get full text

Analysis of the Infectious Diseases Fellowship Program Directors Postmatch 2023 Survey by Andrews, Hayden S, Chirch, Lisa M, Luther, Vera P, Shnekendorf, Rachel, Nolan, Nathanial S, Paras, Molly L

“…Abstract The 2023 United States infectious diseases (ID) fellowship match resulted in a large percentage of programs with unfilled positions. A survey was sent…”
Get full text

Isoniazid-Resistant Tuberculosis of the Parotid Gland Masquerading as a Benign Neoplasm by Lee, Subin, Chirch, Lisa M., Sosa, Lynn, Wu, Qian, Falcone, Todd E.

Get full text

Osteopenia in Patients with HIV Infection Is Not Associated with Elevated sTNFR2 Levels by Chirch, Lisa M., Feiner, Joshua, Go, Roderick, Mynarcik, Dennis, McNurlan, Margaret, Gelato, Marie, Steigbigel, Roy

Get full text

Timing of treatment initiation of direct-acting antivirals for HIV/HCV coinfected and HCV monoinfected patients by Rice, Donald P., Ordoveza, Michelle A., Palmer, Ann M., Wu, George Y., Chirch, Lisa M.

“…Direct-acting antiviral therapy is safe and cost-effective for the treatment of hepatitis C virus (HCV) infection. However, variability in drug payment rules…”
Get full text

Raltegravir in combination with other antiretroviral agents for the treatment of HIV infection by Chirch, Lisa M, Steigbigel, Roy T

“…Raltegravir, an inhibitor of the HIV-1 integrase enzyme, is the first available agent in a new class of antiretroviral drugs. Raltegravir has been studied…”
Get full text

Metabolic Complications of HIV Infection by Chirch, Lisa M, Luthra, Pooja, Mirza, Faryal

“…Objective: To review the metabolic complications of HIV infection. Methods: Review of the literature in the context of 3 clinical cases. Results: People with…”
Get full text

Tuberculosis and interleukin blocking monoclonal antibodies: Is there risk? by Kelsey, Andrew, Chirch, Lisa M, Payette, Michael J

“…Several new monoclonal antibodies that interfere with interleukin (IL) cascades have come to market in recent years. They follow a generation of drugs that…”
Get full text

Virtual Recruitment Is Here to Stay: A Survey of ID Fellowship Program Directors and Matched Applicants Regarding Their 2020 Virtual Recruitment Experiences by Rockney, Danica, Benson, Constance A, Blackburn, Brian G, Chirch, Lisa M, Konold, Victoria J L, Luther, Vera P, Razonable, Raymund R, Tackett, Sean, Melia, Michael T

“…Abstract Background Graduate Medical Education training programs transitioned to all-virtual recruitment in 2020. Limited data have been published regarding…”
Get full text

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part II. Screening for patients on tumor necrosis factor-alfa antagonists by Chirch, Lisa M, Cataline, Philip R, Dieckhaus, Kevin D, Grant-Kels, Jane M

“…Tumor necrosis factor-alfa levels are linked to disease severity in patients with inflammatory conditions, such as psoriasis. Inhibitors of this cytokine are…”
Get full text

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor-alfa antagonists: Part I. Risks associated with tumor necrosis factor-alfa antagonists by Chirch, Lisa M, Cataline, Philip R, Dieckhaus, Kevin D, Grant-Kels, Jane M

“…Tumor necrosis factor-alfa levels are linked to disease severity in patients with inflammatory conditions, such as psoriasis. Inhibitors of this cytokine are…”
Get full text

HIV and aging: a clinical journey from Kochʼs postulate to the chronic disease model and the contribution of geriatric syndromes by Chirch, Lisa M, Hasham, Mohamed, Kuchel, George A

“…PURPOSE OF REVIEWWith the discovery and widespread use of antiretroviral therapies, growing numbers of individuals with HIV are now able to live into advanced…”
Get full text

High-Volume, High-Acuity, and High-Impact Learning: Tips and Tricks for Infectious Diseases Training Programs by Luther, Vera P, Paras, Molly L, Schultz, Sara, Aziz, Mariam, Balba, Gayle, McCarty, Todd P, Razonable, Raymund R, Reece, Rebecca, Shnekendorf, Rachel, Sundareshan, Vidya, Chirch, Lisa M

“…Abstract The Infectious Diseases Society of America Training Program Directors Committee met in October 2022 and discussed an observed increase in clinical…”
Get full text

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor–alfa antagonists by Chirch, Lisa M., MD, Cataline, Philip R., MD, Dieckhaus, Kevin D., MD, Grant-Kels, Jane M., MD

“…Tumor necrosis factor–alfa levels are linked to disease severity in patients with inflammatory conditions, such as psoriasis. Inhibitors of this cytokine are…”
Get full text

Education of Infectious Diseases Fellows During the COVID-19 Pandemic Crisis: Challenges and Opportunities by Chirch, Lisa M, Armstrong, Wendy S, Balba, Gayle P, Kulkarni, Prathit A, Benson, Constance A, Konold, Victoria, Luther, Vera P, Nnedu, Obinna N, Perloff, Sarah, Razonable, Raymund R, Stead, Wendy, Thompson, George R, Melia, Michael T

“…Abstract One of the many challenges that has befallen the Infectious Diseases and Graduate Medical Education communities during the coronavirus disease 2019…”
Get full text

Inclusion, Diversity, Access, and Equity in Infectious Diseases Fellowship Training: Tools for Program Directors by Luther, Vera P, Barsoumian, Alice E, Konold, Victoria J L, Vijayan, Tara, Balba, Gayle, Benson, Constance, Blackburn, Brian, Cariello, Paloma, Perloff, Sarah, Razonable, Raymund, Acharya, Kartikey, Azar, Marwan M, Bhanot, Nitin, Blyth, Dana, Butt, Saira, Casanas, Beata, Chow, Brian, Cleveland, Kerry, Cutrell, James B, Doshi, Saumil, Finkel, Diana, Graber, Christopher J, Hazra, Aniruddha, Hochberg, Natasha S, James, Scott H, Kaltsas, Anna, Kodiyanplakkal, Rosy Priya L, Lee, Mikyung, Marcos, Luis, Mena Lora, Alfredo J, Moore, Christopher C, Nnedu, Obinna, Osorio, Georgina, Paras, Molly L, Reece, Rebecca, Salas, Natalie Mariam, Sanasi-Bhola, Kamla, Schultz, Sara, Serpa, Jose A, Shnekendorf, Rachel, Weisenberg, Scott, Wooten, Darcy, Zuckerman, Richard A, Melia, Michael, Chirch, Lisa M

“…Abstract The Infectious Diseases Society of America (IDSA) has set clear priorities in recent years to promote inclusion, diversity, access, and equity (IDA&E)…”
Get full text

Proactive infectious disease approach to dermatologic patients who are taking tumor necrosis factor–alfa antagonists by Chirch, Lisa M., MD, Cataline, Philip R., MD, Dieckhaus, Kevin D., MD, Grant-Kels, Jane M., MD

“…Tumor necrosis factor–alfa levels are linked to disease severity in patients with inflammatory conditions, such as psoriasis. Inhibitors of this cytokine are…”
Get full text

The Addition of High-Risk HPV Testing to Anal Cytology Increases the Identification of Anal Dysplasia in HIV-Infected Patients by Anthony, Paul, Feinn, Richard, Brenner, Bruce, Dieckhaus, Kevin D, Chirch, Lisa M

“…Anal dysplasia (AD) is prevalent in HIV-infected patients. Screening for AD is recommended for high-risk groups, including HIV-infected patients. We evaluated…”
Get more information